Miruna Cretu

DBMol transforms small molecule design by effectively optimizing binding affinities while ensuring chemical validity, setting a new standard for de novo molecular generation.

A single model can simultaneously generate shape-aligned molecules and feasible synthesis plans, overcoming the traditional trade-offs in drug design.

DNA can now encode entirely new-to-nature enzymatic reactions, thanks to a generative model that designs proteins around user-specified chemistries.